Skip to main content

Grafa News and Videos — Page 1499

Latest

Grafa

ARS Pharmaceuticals secures health Canada approval for needle-free epinephrine

ARS Pharmaceuticals (NASDAQ:SPRY) has received Health Canada approval for neffy 2 mg, marking the first time a needle-free epinephrine delivery system has been authorized for the emergency treatment of severe allergic reactions in Canada.

Read more: ARS Pharmaceuticals secures health Canada approval for needle-free epinephrine
Grafa

American Strategic Investment revenue slides following asset dispositions

American Strategic Investment (NYSE:NYC), a real estate investment trust specializing in commercial properties within New York City’s five boroughs, released its financial and operating results for the fourth quarter and full year ended December 31, 2025.

Read more: American Strategic Investment revenue slides following asset dispositions

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift